Invasive Fungal Disease Clinical Trial
Official title:
FungiScope - A Global Emerging Fungal Infection Registry
The objective of this registry is to broaden the knowledge on epidemiology, diagnostic procedures and clinical course of emerging invasive fungal infections.
The specific objectives are: 1. To determine the fungal species causing invasive fungal infection in different parts of the world. 2. To determine the clinical pattern of disease and document procedures performed for confirmation of the diagnosis. 3. To describe the therapeutic regimens used and their efficacy. 4. To share clinical isolates among the contributors of Fungiscope. 5. To develop molecular biology tools for identification of strains in histopathologically proven invasive fungal infection. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05116059 -
To Evaluate the Efficacy and Safety of ABCD in the Treatment of IFD
|
||
| Completed |
NCT01916057 -
Hepatosplenic CANdidiasis : PETscan and Immune Response Analysis
|
N/A | |
| Completed |
NCT03262584 -
Evaluation of NGS for Detection and Follow-up of Fungal Pathogens in Immunocompromised Pediatric Patients
|
||
| Recruiting |
NCT04368559 -
Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation
|
Phase 3 | |
| Not yet recruiting |
NCT06285188 -
Immunomonitoring of Mold Invasive Infections
|
||
| Recruiting |
NCT05569824 -
LFD of Aspergillus Antigen in Paediatrics
|
||
| Completed |
NCT03577509 -
Single Dose Escalations Study of Amphotericin B Colloidal Dispersion In Healthy Subjects in China
|
Phase 1 | |
| Recruiting |
NCT03774316 -
De-escalation - Antifungal Treatment Immunocompromised Patients
|
||
| Recruiting |
NCT05630976 -
Cresemba® in Treating Chinese Patients With IFD Caused by Aspergillus Species or Other Filamentous Fungi
|
Phase 4 | |
| Completed |
NCT01259713 -
Prevention of Invasive Fungal Infections (IFIs) in Subjects Receiving Chemotherapy for Acute Lymphoblastic Leukemia
|
Phase 3 | |
| Recruiting |
NCT01135589 -
Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation
|
Phase 4 |